-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Solid Biosciences, Raises Price Target to $17

Benzinga·03/12/2026 15:14:33
Listen to the news
Wedbush analyst Laura Chico maintains Solid Biosciences (NASDAQ:SLDB) with a Outperform and raises the price target from $14 to $17.